Software Healthcare Sector

NewCardio

Market Cap: US$40.0

A cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development.

MedLink International

Market Cap: US$40.0

Engages in selling, implementing, and supporting software solutions that provide physician practices, laboratories, and other healthcare organizations access to clinical, administrative, and financial data.

Claritas Pharmaceuticals

Market Cap: US$37.0

A clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs.

WellQuest Medical & Wellness

Market Cap: US$35.0

Provides an integrated medical delivery site with family physician healthcare, preventive/wellness, and medical skin-care services.

Aspyra

Market Cap: US$34.0

Provides health care products and services for the laboratory and imaging marketplaces.

WOWI

Market Cap: US$33.0

An early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States.

Intellipharmaceutics International

Market Cap: US$33.0

A pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States.

Turbine Aviation

Market Cap: US$33.0

A development stage company, through its subsidiary, H7 Security Systems, Inc., develops and markets homeland security products.

Deltagen

Market Cap: US$32.0

Provides drug discovery tools and services to the biopharmaceutical industry.

LifeHOUSE Holdings

Market Cap: US$30.0

Operates senior assisted and independent living, and skilled nursing facilities in the United States.

Monarch Staffing

Market Cap: US$30.0

Provides healthcare staffing services to healthcare providers, state institutions, and related organizations in California.

New Leaf Ventures

Market Cap: US$29.0

Engages in processing, packaging, marketing, and distributing cannabis and related products.

HAVN Life Sciences

Market Cap: US$28.0

A biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.

Neurobiological Technologies

Market Cap: US$27.0

Operates under a plan of liquidation and dissolution approved by stockholders in October 2009.

Lombard Medical

Market Cap: US$27.0

A medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally.

Binovi Technologies

Market Cap: US$26.0

Engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.

TetraLogic Pharmaceuticals

Market Cap: US$24.0

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases.

VMT Scientific

Market Cap: US$24.0

Engages in the design, development, testing, and patenting of medical technologies for use in tissue histogenesis.

Longport

Market Cap: US$23.0

Develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States.

Verde Science

Market Cap: US$23.0

A pharmaceutical research and development company, focuses on developing a portfolio of cannabinoid based prescription medicines for various medical conditions.

Regnum

Market Cap: US$22.0

Develops and commercializes therapeutics that treat rare and infectious diseases.

VIA Pharmaceuticals

Market Cap: US$20.0

A development stage biotechnology company, focuses on the development of compounds for the treatment of cardiovascular and metabolic diseases.

Corix Bioscience

Market Cap: US$20.0

Engages in the manufacture of certified organic cannabidol oil.

Blackwell Intelligence

Market Cap: US$20.0

Engages in cannabis-related business.

Lowell Farms

Market Cap: US$18.0

Engages in the cultivation, extraction, processing, manufacturing, branding, packaging, and wholesale distribution of cannabis products to retail dispensaries in California.

West Island Brands

Market Cap: US$17.0

Operates as a cannabis company in Canada.

ThermoGenesis Holdings

Market Cap: US$15.0

Develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally.

Xcorporeal

Market Cap: US$15.0

Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010.

IMV

Market Cap: US$14.0

Operates as a clinical-stage immuno-oncology company.

PhaseRx

Market Cap: US$11.0

A biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy.

American Medical Technologies

Market Cap: US$10.0

Develops, manufactures, and markets dental related equipment.

Imagin Medical

Market Cap: US$10.0

A urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry.

Easy Technologies

Market Cap: US$10.0

Does not have significant operations.

Vasamed

Market Cap: US$8.0

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States.

Speedus

Market Cap: US$4.0

Through its subsidiaries, engages in the development of diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists, and other healthcare professionals in the United States.

Acusphere

Market Cap: US$4.0

Operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs.